奥洛兹美医疗
HALO
和黄医药
HCM
Lantheus
LNTH
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
天睿公司
TDC
美股市场个股详情
ADXN Addex Therapeutics
- 7.9800
- -0.3900-4.66%
收盘价 01/06 16:00 (美东)
853.02万总市值3.01市盈率TTM
8.9300最高价7.9800最低价7597股成交量8.9300今开8.3700昨收6.53万成交额1.42%换手率亏损市盈率(静)106.89万总股本27.900052周最高0.70市净率427.02万流通值6.450152周最低--股息TTM53.51万流通股750.4000历史最高--股息率TTM11.35%振幅5.0000历史最低8.5950平均价1股每手
Addex Therapeutics关键统计数据
季报+年报
显示同比
| (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | (FY)2022/12/31 | (Q4)2022/12/31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | -83.57%5.38万 | -81.73%11.53万 | -53.39%23.35万 | 13.39%161.3万 | -74.10%15.35万 | -19.95%32.77万 | 244.08%63.09万 | 111.14%50.09万 | -51.22%142.24万 | 49.04%59.24万 |
| 营业收入 | -83.57%5.38万 | -81.73%11.53万 | -53.39%23.35万 | 13.39%161.3万 | -74.10%15.35万 | -19.95%32.77万 | 244.08%63.09万 | 111.14%50.09万 | -51.22%142.24万 | 49.04%59.24万 |
| 主营业务成本 | ||||||||||
| 毛利 | ||||||||||
| 营业费用 | -37.23%67.6万 | -1.21%101.46万 | 17.62%102.16万 | -45.79%1,189.44万 | 118.12%892.18万 | -76.47%107.7万 | -85.88%102.71万 | -85.52%86.85万 | 19.11%2,194.22万 | -12.47%409.04万 |
| 销售和管理费用 | -28.85%33.72万 | -14.48%50.72万 | 13.27%57.17万 | -28.78%720.49万 | 118.71%563.31万 | -80.17%47.4万 | -71.79%59.3万 | -83.44%50.48万 | 30.59%1,011.59万 | 44.05%257.56万 |
| -管理费用 | -28.85%33.72万 | -14.48%50.72万 | 13.27%57.17万 | -28.78%720.49万 | 118.71%563.31万 | -80.17%47.4万 | -71.79%59.3万 | -83.44%50.48万 | 30.59%1,011.59万 | 44.05%257.56万 |
| 研发费用 | -81.52%7.78万 | -19.51%18.45万 | -10.40%17.91万 | -72.60%274.84万 | 71.38%189.82万 | -75.76%42.12万 | -95.10%22.92万 | -92.03%19.99万 | 11.27%1,002.98万 | -55.11%110.76万 |
| 折旧摊销及损耗 | 1,723.52%5.36万 | 3,725.12%11.24万 | 0.00%2,938 | -5.32%30.6万 | 292.79%29.71万 | -96.20%2,938 | -96.47%2,938 | -96.62%2,938 | -7.04%32.31万 | -8.82%7.56万 |
| -折旧及摊销 | 1,723.52%5.36万 | 3,725.12%11.24万 | 0.00%2,938 | -5.32%30.6万 | 292.79%29.71万 | -96.20%2,938 | -96.47%2,938 | -96.62%2,938 | -7.04%32.31万 | -8.82%7.56万 |
| 其他营业费用 | 15.92%20.74万 | 4.29%21.06万 | 66.37%26.78万 | 10.99%163.51万 | 229.73%109.34万 | -51.80%17.89万 | -51.11%20.19万 | -54.99%16.1万 | 12.10%147.33万 | -0.91%33.16万 |
| 营业利润 | 16.96%-62.22万 | -127.00%-89.93万 | -114.36%-78.81万 | 49.89%-1,028.14万 | -150.67%-876.83万 | 82.02%-74.92万 | 94.41%-39.62万 | 93.62%-36.77万 | -32.33%-2,051.97万 | 18.18%-349.8万 |
| 净非营业利息收入（费用） | -103.69%-484 | -94.93%643 | -70.02%6,960 | 315.60%4.24万 | -137.90%-6,663 | 572.11%1.31万 | 204.58%1.27万 | 204.02%2.32万 | 65.95%-1.96万 | 304.66%1.76万 |
| 利息收入 | -99.25%102 | -88.71%1,507 | -68.22%7,571 | 118.67%6.4万 | -48.20%1.31万 | 278.86%1.37万 | 6,443.63%1.33万 | 24,980.00%2.38万 | 449.62%2.93万 | 3,261.67%2.53万 |
| 利息费用 | 8.92%586 | 29.73%864 | 0.33%611 | -55.81%2.16万 | 154.85%1.98万 | -91.57%538 | -94.60%666 | -97.28%609 | -22.40%4.89万 | -16.88%7,767 |
| 其他净收入（费用） | -3,665.08%-90.49万 | -304.71%-55.81万 | 279.72%4.6万 | -20.02%-31.73万 | -4.96%-17.92万 | -59.14%2.54万 | -17.95%-13.79万 | 34.15%-2.56万 | -224.88%-26.44万 | -22.00%-17.07万 |
| 出售证券收益 | -218.02%-3万 | 80.17%-2.73万 | 279.72%4.6万 | -20.02%-31.73万 | -4.96%-17.92万 | -59.14%2.54万 | -17.95%-13.79万 | 34.15%-2.56万 | -224.88%-26.44万 | -22.00%-17.07万 |
| 股权收益 | ---87.49万 | ---53.07万 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| 税前利润 | -114.93%-152.76万 | -179.40%-145.68万 | -98.69%-73.52万 | 49.26%-1,055.62万 | -145.21%-895.41万 | 82.70%-71.07万 | 92.78%-52.14万 | 93.65%-37万 | -35.52%-2,080.42万 | 17.46%-365.16万 |
| 所得税 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 除税后利润 | 41.54%-153万 | 581.42%1,287.86万 | -28.25%-308.71万 | 49.26%-1,055.62万 | 21.76%-285.68万 | 36.29%-261.71万 | 62.95%-267.52万 | 58.67%-240.72万 | -35.52%-2,080.42万 | 17.46%-365.16万 |
| 持续经营利润 | -114.93%-152.76万 | -179.40%-145.68万 | -98.69%-73.52万 | 49.26%-1,055.62万 | -145.21%-895.41万 | 82.70%-71.07万 | 92.78%-52.14万 | 93.65%-37万 | -35.52%-2,080.42万 | 17.46%-365.16万 |
| 停止经营利润 | 99.87%-2,400 | 765.60%1,433.54万 | -15.45%-235.2万 | ---- | ---- | ---190.63万 | ---215.38万 | ---203.72万 | ---- | ---- |
| 归属于少数股东的净利润 | ||||||||||
| 归属于母公司的净利润 | 41.54%-153万 | 581.42%1,287.86万 | -28.25%-308.71万 | 49.26%-1,055.62万 | 21.76%-285.68万 | 36.29%-261.71万 | 62.95%-267.52万 | 58.67%-240.72万 | -35.52%-2,080.42万 | 17.46%-365.16万 |
| 优先股派息 | ||||||||||
| 其他优先股派息 | ||||||||||
| 归属于普通股股东的净利润 | 41.54%-153万 | 581.42%1,287.86万 | -28.25%-308.71万 | 49.26%-1,055.62万 | 21.76%-285.68万 | 36.29%-261.71万 | 62.95%-267.52万 | 58.67%-240.72万 | -35.52%-2,080.42万 | 17.46%-365.16万 |
| 基本每股收益 | 33.33%-2.4 | 425.00%15.6 | 25.00%-3.6 | 69.57%-16.8 | 25.00%-3.6 | 66.67%-3.6 | 78.95%-4.8 | 73.33%-4.8 | -2.22%-55.2 | 69.23%-4.8 |
| 稀释每股收益 | 33.33%-2.4 | 300.00%9.6 | 25.00%-3.6 | 69.57%-16.8 | 25.00%-3.6 | 66.67%-3.6 | 78.95%-4.8 | 73.33%-4.8 | -2.22%-55.2 | 69.23%-4.8 |
| 每股派息 | ||||||||||
| 货币单位 | 瑞士法郎 | 瑞士法郎 | 瑞士法郎 | 瑞士法郎 | 瑞士法郎 | 瑞士法郎 | 瑞士法郎 | 瑞士法郎 | 瑞士法郎 | 瑞士法郎 |
| 审计意见 | -- | -- | -- | 无保留意见 | -- | -- | -- | -- | -- | -- |
